These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9328480)

  • 1. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.
    Lambert JC; Pérez-Tur J; Dupire MJ; Galasko D; Mann D; Amouyel P; Hardy J; Delacourte A; Chartier-Harlin MC
    Hum Mol Genet; 1997 Nov; 6(12):2151-4. PubMed ID: 9328480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
    Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease.
    Combarros O; Leno C; Oterino A; Berciano J; Fernández-Luna JL; Fernández-Viadero C; Peña N; Miró J; Delgado M
    Acta Neurol Scand; 1998 Jan; 97(1):68-71. PubMed ID: 9482681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.
    Lambert JC; Pasquier F; Cottel D; Frigard B; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Mar; 7(3):533-40. PubMed ID: 9467014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.
    Carrieri G; Bonafè M; De Luca M; Rose G; Varcasia O; Bruni A; Maletta R; Nacmias B; Sorbi S; Corsonello F; Feraco E; Andreev KF; Yashin AI; Franceschi C; De Benedictis G
    Hum Genet; 2001 Mar; 108(3):194-8. PubMed ID: 11354629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
    Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of allelic imbalance in APOE epsilon3/4 brain mRNA expression in Alzheimer's disease.
    Growdon WB; Cheung BS; Hyman BT; Rebeck GW
    Neurosci Lett; 1999 Sep; 272(2):83-6. PubMed ID: 10507547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
    Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
    J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
    Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
    Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease.
    Lambert JC; Coyle N; Lendon C
    J Med Genet; 2004 Feb; 41(2):104-12. PubMed ID: 14757857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.
    Yamamoto Y; Yasuda M; Mori E; Maeda K
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):94-6. PubMed ID: 10369830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
    Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
    Schwab SG; Bagli M; Papassotiropoulos A; Jessen F; Maier W; Rao ML; Heun R
    Dement Geriatr Cogn Disord; 1999; 10(6):469-72. PubMed ID: 10559561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.